Episodios

  • Testing for PFAS ‘forever chemicals’ PART ONE
    Nov 17 2025

    This two-part podcast moderated by Dr. Adam Brown, Cleveland Clinic, features a discussion with Philip Zuccaro, BS, and Vasilis Vasiliou, PhD, both of the Yale School of Public Health, on the Cleveland Clinic Journal of Medicine 1-minute consult article, “Does my patient need testing for PFAS ‘forever chemicals’?”

    Más Menos
    15 m
  • Single-pill combination antihypertensive therapy
    Oct 27 2025

    This podcast moderated by Dr. Craig Nielsen features a discussion with Dr. Maximilian C. Volk, and Dr. Luke J. Laffin, Cleveland Clinic on the Cleveland Clinic Journal of Medicine 1-minute consult article, “Should I consider Cy for my patient with high blood pressure?”

    Más Menos
    25 m
  • Hypercholesterolemia not responding to statins
    Sep 22 2025

    This podcast moderated by Dr. Adam Brown, Cleveland Clinic, features a discussion with Dr. Faaiq N. Aslam, Mayo Clinic, on the Cleveland Clinic Journal of Medicine 1-minute consult article, “My adult patient’s hypercholesterolemia is not responding to statins—what’s next?”

    Más Menos
    23 m
  • Recreational cannabis legalization
    Aug 21 2025

    This podcast features discussion with Dr. Akhil Anand and Dr. Hannah Snyder, and moderated by Dr. Craig Nielsen, all of Cleveland Clinic. Together, they explore the Cleveland Clinic Journal of Medicine article, “Recreational cannabis legalization: Potential implications for individual and community health.” The conversation delves into the multifaceted issues surrounding recreational cannabis legalization, examining potential health and societal outcomes.

    Más Menos
    26 m
  • Psychedelic assisted therapy PART TWO
    Jul 21 2025

    In this two-part podcast, Dr. Brian S. Barnett, Cleveland Clinic, and Dr. Erin E. Mauney, Massachusetts General Hospital for Children, joins moderator Dr. Adam Brown, Cleveland Clinic, to discuss the Cleveland Clinic Journal of Medicine article, “Psychedelic assisted therapy: An overview for the internist.” The trio focuses on what an internist needs to know, from the potential effects, risks, and therapeutic applications of these powerful drugs, with a focus on MDMA-assisted therapy for posttraumatic stress disorder (PTSD) and psilocybin-assisted therapy for depression.

    Más Menos
    27 m
  • Psychedelic assisted therapy PART ONE
    Jun 20 2025

    In this two-part podcast, Dr. Brian S. Barnett, Cleveland Clinic, and Dr. Erin E. Mauney, Massachusetts General Hospital for Children, joins moderator Dr. Adam Brown, Cleveland Clinic, to discuss the Cleveland Clinic Journal of Medicine article, “Psychedelic assisted therapy: An overview for the internist.” The trio focuses on what an internist needs to know, from the potential effects, risks, and therapeutic applications of these powerful drugs, with a focus on MDMA-assisted therapy for posttraumatic stress disorder (PTSD) and psilocybin-assisted therapy for depression.

    Más Menos
    25 m
  • Diabetes technology PART TWO
    May 21 2025

    In this two-part podcast, Dr. Cecila Lansang, Cleveland Clinic, and Dr. Jayachidambaram Ambalavanan, Maine Health, joins moderator Dr. Craig Nielsen, Cleveland Clinic, to discuss the Cleveland Clinic Journal of Medicine article, “Diabetes technology: A primer for clinicians.” The trio discusses the evolution of diabetes technology it’s impact on the way that both patients and clinicians approach the management of diabetes.

    Más Menos
    19 m
  • Diabetes technology PART ONE
    Apr 21 2025

    In this two-part podcast, Dr. Cecila Lansang, Cleveland Clinic, and Dr. Jayachidambaram Ambalavanan, Maine Health, joins moderator Dr. Craig Nielsen, Cleveland Clinic, to discuss the Cleveland Clinic Journal of Medicine article, “Diabetes technology: A primer for clinicians.” The trio discusses the evolution of diabetes technology it’s impact on the way that both patients and clinicians approach the management of diabetes.

    Más Menos
    21 m